CKMT1 inactivation was reported to disrupt the cell cycle and reduce tumor growth in A549 cells (17); however, we found that A549 cells were resistant to cyclocreatine treatment and exhibited low CK activity, suggesting a minor role for endogenous CK in these cells. Here, CKMT1A is linked to neoplasm.